- Phan T. Genetic diversity and evolution of SARS-CoV-2. Infection, Genetics and Evolution. 2020;81:104260. doi: 10.1016/j.meegid.2020.104260.
- Bevelacqua JJ, Mortazavi SAR, Mortazavi SMJ. Re: Low-dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence? Int J Radiat Biol. 2020;1-2. doi: 10.1080/09553002.2020.1797213.
- Mortazavi SMJ, Kefayat A, Cai J. Low-dose radiation as a treatment for COVID-19 pneumonia: A threat or real opportunity? Med Phys. 2020. doi: 10.1002/mp.14367.
- Ghadimi-Moghadam A, Haghani M, Bevelacqua JJ, et al. COVID-19 Tragic Pandemic: Concerns over Unintentional “Directed Accelerated Evolution” of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS. J Biomed Phys Eng. 2020;10(2):241-6. doi: 10.31661/jbpe.v0i0.2003-1085. PubMed PMID: 32337192. PubMed PMCID: PMC7166223.
- Mehdizadeh AR, Bevelacqua JJ, Mortazavi SAR, Mortazavi SMJ. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations. J Biomed Phys Eng. 2020;10(3):247-50. doi: 10.31661/jbpe.v0i0.2005-1114. PubMed PMID: 32637368. PubMed PMCID: PMC7321390.
- Welsh JS, Bevelacqua JJ, Mozdarani H, Mortazavi SAR, Mortazavi SMJ. Why can COVID-19 fatality in space be significantly higher than on Earth? Int J Radiat Res. 2020;18(3):421-6. doi: 10.18869/acadpub.ijrr.18.3.421.
- Grubaugh ND, Hanage WP, Rasmussen AL. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear. Cell. 2020. doi: 10.1016/j.cell.2020.06.040.
- Harris DR, Pollock SV, Wood EA, et al, Eggington J, Durfee TJ, Middle CM. Directed evolution of ionizing radiation resistance in Escherichia coli. J Bacteriol. 2009;191(16):5240-52. doi: 10.1128/JB.00502-09. PubMed PMID: 19502398. PubMed PMCID: PMC2725583.
- Mortazavi SAR, Khademi F, Motamedifar M, Haghani M, Mortazavi SMJ. Human-Induced Radioresistance as a Possible Mechanism for Producing Biological Weapons: A Feasible Bridge between Radioresistance and Resistance to Antibiotics and Genotoxic Agents. Iranian Journal of Public Health. 2014;43(2):247-8.
- Ghadimi-Moghadam A, Haghani M, Bevelacqua JJ, et al. COVID-19 tragic pandemic: concerns over unintentional “directed accelerated evolution” of novel Coronavirus (SARS-CoV-2) and introducing a modified treatment method for ARDS. J Biomed Phys Eng. 2020;10(2):241-6. doi: 10.31661/jbpe.v0i0.2003-1085. PubMed PMID: 32337192. PubMed PMCID: PMC7166223.
- Korber B, Fischer WM, Gnanakaran S, Yoon H, et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020. doi: 10.1016/j.cell.2020.06.043.
- Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, et al. COVID-19: A promising cure for the global panic. Science of the Total Environment. 2020;725:138277. doi: 10.1016/j.scitotenv.2020.138277.
- Helmy YA, Fawzy M, Elaswad A, et al. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clinical Med. 2020;9(4):1225. doi: 10.3390/jcm9041225. PubMed PMID: 32344679. PubMed PMCID: PMC7230578.
- Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y. Targeting SARS-CoV-2 Receptors as a Means for Reducing Infectivity and Improving Antiviral and Immune Response: An Algorithm-based Method For Overcoming Resistance To Antiviral Agents. Emerg Microbes Infect. 2020;9(1):1397-406. doi: 10.1080/22221751.2020.1776161. PubMed PMID: 32490731.
- Crossan C. Mutating coronavirus: what it means for all of us. Medical Xpress, 2020. [Online]. Available from: https://medicalxpress.com/news/2020-06-mutating-coronavirus.html.
|